CJC-1295 without DAC: dosing cadence resembles ipamorelin (multiple subcutaneous administrations per day) because, without the DAC moiety, the half-life collapses to roughly 30 minutes
Besides diabetes, GLP - 1RAs have exhibited gut microbiota - modifying effects in other metabolic disorders, especially some bacteria associated with glycolipid metabolism and intestinal inflammation (Madsen et al., 2019)
thyroid cancer or hyperthyroidism, gastroparesis, pancreatic cancer or pancreatitis, MEN2 syndrome, or inflammatory bowel disease)
Existing data shows there is a significantly (28 times) higher risk of gastric cancer among individuals with AIG, chronic atrophic gastritis, and PA [27]
Wegovy mimics GLP-1 to suppress appetite and support weight loss